The control of an action in Parkinson's disease

被引:34
|
作者
Gentilucci, M [1 ]
Negrotti, A [1 ]
机构
[1] Ist Fisiol Umana, I-43100 Parma, Italy
关键词
Parkinson's disease; kinematics; action; reaching-grasping; placing;
D O I
10.1007/s002210050897
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied, in Parkinson's disease (PD) patients and healthy control subjects, the kinematics of the action formed by two successive motor acts: reaching-grasping an object (first target) and placing it on a second target. We examined the effects of extrinsic (i.e., distance) and intrinsic (i.e., size) properties of the second target on the various kinematic phases of reaching-grasping. We randomly varied distance and size of both stimuli across the experimental session. The kinematics of the reach initial phase of both patients and controls was influenced by the distance of both the first and the second target. In particular, peak acceleration increased far farther position of the second target. However, in the subsequent phase, patients, differently from controls, modified their reaching kinematics, removing the effects of second target position. These results were due neither to a visual interference effect of the second target on reaching-grasping nor to the complexity of movement sequence. Finally, the size of the second target did not affect grasp kinematics of both patients and controls. The results of the present study support the hypothesis that PD patients are able to compute the general program of an action in which extrinsic properties of both the actual and the final target are computed. However, PD patients re-program movement during its execution. This suggests a decay of the motor program. That is, basal ganglia can be involved in storing the plan of an action and in controlling its correct execution.
引用
收藏
页码:269 / 277
页数:9
相关论文
共 50 条
  • [1] The control of an action in Parkinson’s disease
    M. Gentilucci
    Anna Negrotti
    Experimental Brain Research, 1999, 129 : 269 - 277
  • [2] Virtual action planning in Parkinson's disease: A control study
    Klinger, Evelyne
    Chemin, Isabelle
    Lebreton, Sophie
    Marie, Rose-Marie
    CYBERPSYCHOLOGY & BEHAVIOR, 2006, 9 (03): : 342 - 347
  • [3] Dysfunctional action control as a specific feature of Parkinson's disease
    Marzinzik, Frank
    Herrmann, Anja
    Gogarten, Jacob H.
    Lueschow, Andreas
    Weber, Joachim E.
    Schindlbeck, Katharina A.
    Klostermann, Fabian
    JOURNAL OF NEURAL TRANSMISSION, 2015, 122 (08) : 1125 - 1133
  • [4] Dysfunctional action control as a specific feature of Parkinson’s disease
    Frank Marzinzik
    Anja Herrmann
    Jacob H. Gogarten
    Andreas Lueschow
    Joachim E. Weber
    Katharina A. Schindlbeck
    Fabian Klostermann
    Journal of Neural Transmission, 2015, 122 : 1125 - 1133
  • [5] The effect of Parkinson's disease on interference control during action selection
    Wylie, S. A.
    van den Wildenberg, W. P. M.
    Ridderinkhof, K. R.
    Bashore, T. R.
    Powell, V. D.
    Manning, C. A.
    Wooten, G. F.
    NEUROPSYCHOLOGIA, 2009, 47 (01) : 145 - 157
  • [6] A model-based quantification of action control deficits in Parkinson's disease
    Servant, Mathieu
    van Wouwe, Nelleke
    Wylie, Scott A.
    Logan, Gordon D.
    NEUROPSYCHOLOGIA, 2018, 111 : 26 - 35
  • [7] Parkinson's disease and the internal control of action: A single-case study
    Jackson, SR
    Morris, DL
    Harrison, J
    Henderson, L
    Kennard, C
    NEUROCASE, 1995, 1 (03) : 267 - 283
  • [8] Impulse control in Parkinson's disease: Distinct effects between action and choice
    Warden, Aliya C. M.
    Mcallister, Craig
    Ruitenberg, Marit F. L.
    Macdonald, Hayley J.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2025, 169
  • [9] Apomorphine infusion does not impair cognitive action control in Parkinson's disease
    Duprez, J.
    Houvenaghel, J. F.
    Drapier, S.
    Drapier, D.
    Verin, M.
    Sauleau, P.
    MOVEMENT DISORDERS, 2017, 32
  • [10] Parkinson's disease: News on the action of melatonin
    Scorza, Fulvio A.
    Wuo-Silva, Raphael
    Finsterer, Josef
    Chaddad-Neto, Feres
    SLEEP MEDICINE, 2025, 130 : 1 - 2